Last reviewed · How we verify
NCT07061925
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
Phase 2 trial testing ALC-2203-1 in Acute Bronchitis in 169 participants. Completed in 26 November 2025.
21 November 2025
Quick facts
| Lead sponsor | Korea Arlico Pharm. Co., Ltd |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 169 |
| Start date | 23 April 2025 |
| Primary completion | 21 November 2025 |
| Estimated completion | 26 November 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- ALC-2203-1 — full drug profile →
- ALC-2203-2 — full drug profile →
- ALC-2203-AC — full drug profile →
- Placabo — full drug profile →
Conditions studied
- Acute Bronchitis — all drugs for Acute Bronchitis →
Sponsor
Korea Arlico Pharm. Co., Ltd — full company profile →
Who can join
19 and older, any sex, with Acute Bronchitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter, Dose-finding, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of ALC-2203 in Patients with Acute Bronchitis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07061925
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Bronchitis
Currently open trials in the same condition.
- NCT07359287 — Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07061925 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korea Arlico Pharm. Co., Ltd
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07061925.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing